Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2017 Financial Results and Provide Corporate Update on Wednesday, March 14
Conference Call & Webcast Information
Dial-in: (877) 643-7155 (
Conference ID: 2074279
Please join the conference call at least 10 minutes early to register. You can access the live webcast under the investor relations section of Arena's website at: www.arenapharm.com. A replay of the conference call will be archived under the investor relations section of Arena's website for 30 days after the call.
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about Arena's financial results announcement, focus, and the potential of its programs and collaborations. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the
Executive Vice President and
Chief Financial Officer
Matt Middleman, M.D.
LifeSci Public Relations
View original content with multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2017-financial-results-and-provide-corporate-update-on-wednesday-march-14-300610510.html